Clinical Trials Directory

Trials / Conditions / Hepatocellular Carcinoma Recurrent

Hepatocellular Carcinoma Recurrent

16 registered clinical trials studyying Hepatocellular Carcinoma Recurrent — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingGNB4 and Riplet Gene Methylation Combined Detection Kit for Hepatocellular Carcinoma Recurrence Monitoring
NCT07489768
Tongji Hospital—
RecruitingSafety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
NCT06254248
Assistance Publique - Hôpitaux de ParisPhase 2
RecruitingTheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
NCT07118202
Barbara Ann Karmanos Cancer InstituteN/A
RecruitingA Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
NCT05417932
SCG Cell Therapy Pte. Ltd.Phase 1 / Phase 2
TerminatedA Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types K
NCT05497453
Omega TherapeuticsPhase 1 / Phase 2
UnknownBevacizumab Biosimilar Plus FOLFOX4 in the Treatment of Recurrent HCC After Liver Transplantation
NCT05355155
The First Affiliated Hospital with Nanjing Medical UniversityPhase 2
UnknownRisk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcino
NCT05990959
China Medical University Hospital—
UnknownRadiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study
NCT05277675
Southwest Hospital, ChinaN/A
UnknownHeterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence
NCT04506398
RenJi Hospital—
UnknownPembrolizumab and LENvatinib in Participants With Hepatocellular Carcinoma (HCC) Before Liver Transplant
NCT04425226
RenJi HospitalN/A
UnknownA RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resec
NCT04392700
Sun Yat-sen UniversityPhase 3
WithdrawnQUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine
NCT03563170
ImmunityBio, Inc.Phase 1 / Phase 2
UnknownA Study of Laparoscopic Hepatectomy Versus RFA in the Treatment of Recurrent HCC
NCT03313648
Southwest Hospital, ChinaN/A
CompletedA Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in R
NCT02423343
Eli Lilly and CompanyPhase 1 / Phase 2
TerminatedEfficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
NCT01009593
AbbottPhase 3
CompletedAssociation Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Tran
NCT06233708
Asan Medical Center—